These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11814469)

  • 21. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
    Mironova MA; Klein RL; Virella GT; Lopes-Virella MF
    Diabetes; 2000 Jun; 49(6):1033-41. PubMed ID: 10866057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
    Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus.
    Nakhjavani M; Asgharani F; Khalilzadeh O; Esteghamati A; Ghaneei A; Morteza A; Anvari M
    Am J Med Sci; 2011 Feb; 341(2):92-5. PubMed ID: 20890173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibodies against low density oxidized lipoproteins in type 2 diabetics].
    Malícková K; Skrha J; Janatková I; Vanková Z; Fucíková T
    Epidemiol Mikrobiol Imunol; 2004 Aug; 53(3):131-5. PubMed ID: 15524272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis.
    Bui MN; Sack MN; Moutsatsos G; Lu DY; Katz P; McCown R; Breall JA; Rackley CE
    Am Heart J; 1996 Apr; 131(4):663-7. PubMed ID: 8721636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody.
    Wang J; Zhang C; Gong J; Zhu Y; Fu L; Wang X; Li K
    Clin Chim Acta; 2007 Oct; 385(1-2):73-8. PubMed ID: 17719023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autophagy of human vascular endothelial cells by oxidized low-density lipoprotein: involvement of oxidative stress but no oxidized low density lipoprotein-1].
    Han Q; Zhang YL; You SJ; Liu HH; Cao YJ; Chen R; Liu CF
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2216-20. PubMed ID: 22094043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated beta2-glycoprotein I-low-density lipoprotein levels are associated with the presence of diabetic microvascular complications.
    Yu R; Yuan Y; Niu D; Song J; Liu T; Wu J; Wang J
    J Diabetes Complications; 2015; 29(1):59-63. PubMed ID: 25449980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress.
    Fang Y; Li J; Ding M; Xu X; Zhang J; Jiao P; Han P; Wang J; Yao S
    Exp Biol Med (Maywood); 2014 Dec; 239(12):1678-87. PubMed ID: 24962173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes.
    Devaraj S; Hirany SV; Burk RF; Jialal I
    Clin Chem; 2001 Nov; 47(11):1974-9. PubMed ID: 11673365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males.
    Barud W; Palusiński R; Bełtowski J; Wójcicka G
    Atherosclerosis; 2002 Oct; 164(2):283-8. PubMed ID: 12204799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies against modified low-density lipoproteins in coronary artery disease.
    Tornvall P; Waeg G; Nilsson J; Hamsten A; Regnström J
    Atherosclerosis; 2003 Apr; 167(2):347-53. PubMed ID: 12818418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative Modification of LDL by Various Physicochemical Techniques: Its Probable Role in Diabetes Coupled with CVDs.
    Alouffi S; Faisal M; Alatar AA; Ahmad S
    Biomed Res Int; 2018; 2018():7390612. PubMed ID: 30581866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients.
    Nakhjavani M; Morteza A; Asgarani F; Mokhtari A; Esteghamati A; Khalilzadeh O; Rahbari G
    Redox Rep; 2011; 16(5):193-200. PubMed ID: 22005339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
    Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
    Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease.
    Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S
    J Am Coll Cardiol; 2001 Mar; 37(3):775-9. PubMed ID: 11693751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR; Hurley BL; Simpson DF; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes.
    Morteza A; Nakhjavani M; Ghadiri-Anari A; Esteghamati A; Khalilzadeh O
    Eur Cytokine Netw; 2011 Jun; 22(2):107-12. PubMed ID: 21636350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.